If you’ve spent five minutes scrolling through a health forum in 2026, you’ve seen a recurring theme: patients are overwhelmed. Between AI-generated medical advice and the endless sea of unverified social media influencers, finding a straight answer has become a full-time job.
Health Union and solli’s 2026 Pharma Marketing Pulse Survey highlights a stark reality for our industry. We are no longer just competing for “share of voice.” We are competing for share of trust.
As marketers, we have to ask ourselves: In a world where anyone can generate a medical-sounding article in seconds, why should a patient believe us?
The End of the “General Search” Era
For years, the playbook was simple: win the search term, get the click, and drive them to the brand site. But the “zero-click” reality has changed the game, and when AI summaries provide answers directly on the search page, the casual browser never makes it to your carefully-crafted website.
The survey shows that 68% of marketers are reacting by shifting budgets away from broad search and toward high-authority, niche platforms. Why? When the stakes are high, like a new oncology diagnosis or a rare disease flare, patients don’t want a summary, they want a source. They are seeking platforms where medical review is driven by real experts, not just algorithms. In 2026, authority is the new SEO.
Trust by Association: The Company You Keep
The survey found that 45% of respondents are intentionally increasing spend on platforms that demonstrate high levels of medical authority.
This isn’t just about avoiding “fake news.” It’s about contextual credibility. If your brand’s life-changing therapy is advertised next to a dubious “wellness hack” on a generic social feed, your credibility takes a hit by association. However, when that same message appears within a moderated, peer-to-peer community like those we build at Health Union, it inherits the trust of the ecosystem.
Closing the “Validation Loop”
Trust isn’t just a one-way street from the brand to the patient; it has to survive the doctor’s office.
One of the most telling stats from the 2026 survey is that while we all crave “synergy,” 93% of budgets are still siloed between DTC and HCP teams. This creates a “trust gap” at the most critical moment. If a patient finds a resource they trust, but their doctor hasn’t seen that same high-authority data, the trust evaporates the moment the doctor says, “I’m not familiar with that.”
True leadership in 2026 means ensuring that the authority we build with patients is mirrored in the data we provide to HCPs. It’s about creating a unified “circle of trust” around the patient.
The 2026 Litmus Test
As we move through the year, the most successful pharma leaders won’t be those with the biggest AI budgets. They will be the ones who pass the “Trust Test”:
- Is our content vetted by humans? (Not just generated by bots.)
- Are we showing up in safe, moderated spaces? (Not just broad, chaotic feeds.)
- Are we empowering the patient-physician dialogue? (Not just shouting at one side.)
The Bottom Line
In 2026, trust is fragile, and authority is hard-won. We have the tools to reach more people than ever before, but without a foundation of credibility, those reaches are just noise. It’s time to stop chasing the “click” and start investing in the authority that keeps patients safe and brands relevant.
